Skip to search formSkip to main contentSkip to account menu

CBLB502

Known as: TLR5 Agonist CBLB502 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Peptides

Narrower (1)

entolimod

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Comparative study of the effects of rhKGF, CBLB502 and WR2721 on radiation-induced oral mucositis
Objective　To compare the protective effect of rhKGF, CBLB502 and WR2721 on radiation-induced oral mucositis (ROM). Methods　Fifty… 
2012
2012
Abstract 4398: Liver is a major primary target for the Toll-like receptor-5 agonist CBLB502 providing radioprotective, antimicrobial and antitumor responses
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL We have previously shown that activation of Toll… 
Review
2010
Review
2010
FDA Pipeline Preview, December 2010 (Ezogabine, Solesta, Dutasteride, Finasteride, Octaplex, SF1126, MP4CO, Ensituximab, Naloxone, CBLB502)
Recent FDA action (through, November 2010) related to Ezogabine, Solesta, Dutasteride, Finasteride, Octaplex, SF1126, MP4CO… 
2008
2008
Therapy: Reversed protection
Toxic side effects of radiotherapy are largely determined by massive apoptosis in the haematopoietic system and/or…